-+ 0.00%
-+ 0.00%
-+ 0.00%

CYTOKINETICS ANNOUNCES MHRA MARKETING AUTHORISATION FOR MYQORZO®▼ (AFICAMTEN) AND POSITIVE GUIDANCE FROM NICE FOR SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN ENGLAND AND WALES

Reuters·07/30/2026 10:20:00

Please log in to view news